NCT01964885View on ClinicalTrials.gov

Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections

PHASE3TerminatedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Common ColdUpper Respiratory Tract Infections
Interventions
DIETARY_SUPPLEMENT

IQP-AS-105

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

10369

Udo Bongartz, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY